These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7614179)

  • 21. Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
    Walsh TJ; Gonzalez CE; Piscitelli S; Bacher JD; Peter J; Torres R; Shetti D; Katsov V; Kligys K; Lyman CA
    J Clin Microbiol; 2000 Jun; 38(6):2369-73. PubMed ID: 10835005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of sargramostim (rh-GM-CSF) as adjunctive treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS: a pilot study.
    Vazquez JA; Hidalgo JA; De Bono S
    HIV Clin Trials; 2000; 1(3):23-9. PubMed ID: 11590502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
    Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
    AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients.
    Martins MD; Lozano-Chiu M; Rex JH
    Clin Infect Dis; 1997 Oct; 25(4):843-6. PubMed ID: 9356799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter.
    Wu CJ; Lee HC; Yang YL; Chang CM; Chen HT; Lin CC; Lee NY; Chu WL; Hsieh LY; Wang YL; Lauderale TL; Tseng FC; Ko NY; Ko WC; Lo HJ
    Clin Microbiol Infect; 2012 May; 18(5):485-90. PubMed ID: 21939471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
    Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of fluconazole-resistant strains of Candida albicans in otherwise healthy outpatients.
    Haberland-Carrodeguas C; Allen CM; Beck FM; Buesching WJ; Koletar SL; Sundstrom P
    J Oral Pathol Med; 2002 Feb; 31(2):99-105. PubMed ID: 11896831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors for the clinical effectiveness of fluconazole in the treatment of oral candidiasis in HIV-1-infected individuals.
    Koks CH; Crommentuyn KM; Mathôt RA; Mulder JW; Meenhorst PL; Beijnen JH
    Pharmacol Res; 2002 Jul; 46(1):89-94. PubMed ID: 12208126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
    Revankar SG; Kirkpatrick WR; McAtee RK; Dib OP; Fothergill AW; Redding SW; Rinaldi MG; Patterson TF
    J Infect Dis; 1996 Oct; 174(4):821-7. PubMed ID: 8843222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review.
    White A; Goetz MB
    Clin Infect Dis; 1994 Oct; 19(4):687-92. PubMed ID: 7803633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluconazole for ketoconazole-resistant oropharyngeal candidiasis in HIV-1 infected patients.
    Thorsen S; Mathiesen LR
    Scand J Infect Dis; 1990; 22(3):375-6. PubMed ID: 2371551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
    Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
    Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluconazole-resistant Candida in AIDS patients. Report of two cases.
    Heinic GS; Stevens DA; Greenspan D; MacPhail LA; Dodd CL; Stringari S; Strull WM; Hollander H
    Oral Surg Oral Med Oral Pathol; 1993 Dec; 76(6):711-5. PubMed ID: 8284074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870.
    Hood SV; Hollis S; Percy M; Atkinson G; Williams K; Denning DW
    Clin Infect Dis; 1999 Mar; 28(3):587-96. PubMed ID: 10194083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida].
    Zhao M; Zhou ZT
    Shanghai Kou Qiang Yi Xue; 2006 Apr; 15(2):218-20. PubMed ID: 16685371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.
    Redding S; Smith J; Farinacci G; Rinaldi M; Fothergill A; Rhine-Chalberg J; Pfaller M
    Clin Infect Dis; 1994 Feb; 18(2):240-2. PubMed ID: 8161633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.